Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ribak

Showing results (391-400 of 400) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 400 results.
Frontiers in Immunology|November 10, 2025
Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center studyAviv Talmon, Oded Shamriz, Limor Rubin, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 26, 2023
Food-induced anaphylaxis during infancy is associated with later sleeping and eating disordersShay Nemet, Daniel Elbirt, Keren Mahlab-Guri, et al.
International Journal of Epidemiology|August 7, 2013
Population health and status of epidemiology: WHO European Region IMati Rahu, Vasiliy V Vlassov, Frank Pega, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 26, 2025
IgE deficiency (<2.5 IU/mL) in children: Clinical insights from a population-based study of 123,393 subjectsShay Nemet, Daniel Elbirt, Ramon Cohen, et al.
Frontiers in Immunology|December 3, 2025
Case Report: A potential novel treatment for drug-induced acute interstitial nephritis: BenralizumabAlexander Saadia, Ron Wald, Assaf Potruch, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 2, 2023
Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for AnaphylaxisYuval Tal, Yaarit Ribak, Limor Rubin, et al.
The Journal of Allergy and Clinical Immunology. Global|February 11, 2025
Clinical significance of very high IgE levels (≥1000 IU/mL): Population-based study of 118,211 adultsShay Nemet, Daniel Elbirt, Ramon Cohen, et al.
The Journal of Allergy and Clinical Immunology. Global|March 11, 2026
Severe eosinophilia and risk of major disease and mortality: A nationwide cohort study of children and adultsShay Nemet, Daniel Elbirt, Ramon Cohen, et al.
American Journal of Industrial Medicine|December 21, 2002
Estimating exposures in the asphalt industry for an international epidemiological cohort study of cancer riskIgor Burstyn, Paolo Boffetta, Timo Kauppinen, et al.
Med (New York, N.Y.)|June 18, 2022
B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodiesIlana Fox-Fisher, Sheina Piyanzin, Mayan Briller, et al.
Pageof 40

Showing results (391-400 of 400) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 400 results.
Frontiers in Immunology|November 10, 2025
Benralizumab for adults with rare and off-label eosinophilic disorders: a 52-week prospective, single-center studyAviv Talmon, Oded Shamriz, Limor Rubin, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 26, 2023
Food-induced anaphylaxis during infancy is associated with later sleeping and eating disordersShay Nemet, Daniel Elbirt, Keren Mahlab-Guri, et al.
International Journal of Epidemiology|August 7, 2013
Population health and status of epidemiology: WHO European Region IMati Rahu, Vasiliy V Vlassov, Frank Pega, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 26, 2025
IgE deficiency (<2.5 IU/mL) in children: Clinical insights from a population-based study of 123,393 subjectsShay Nemet, Daniel Elbirt, Ramon Cohen, et al.
Frontiers in Immunology|December 3, 2025
Case Report: A potential novel treatment for drug-induced acute interstitial nephritis: BenralizumabAlexander Saadia, Ron Wald, Assaf Potruch, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 2, 2023
Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for AnaphylaxisYuval Tal, Yaarit Ribak, Limor Rubin, et al.
The Journal of Allergy and Clinical Immunology. Global|February 11, 2025
Clinical significance of very high IgE levels (≥1000 IU/mL): Population-based study of 118,211 adultsShay Nemet, Daniel Elbirt, Ramon Cohen, et al.
The Journal of Allergy and Clinical Immunology. Global|March 11, 2026
Severe eosinophilia and risk of major disease and mortality: A nationwide cohort study of children and adultsShay Nemet, Daniel Elbirt, Ramon Cohen, et al.
American Journal of Industrial Medicine|December 21, 2002
Estimating exposures in the asphalt industry for an international epidemiological cohort study of cancer riskIgor Burstyn, Paolo Boffetta, Timo Kauppinen, et al.
Med (New York, N.Y.)|June 18, 2022
B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodiesIlana Fox-Fisher, Sheina Piyanzin, Mayan Briller, et al.
Pageof 40